Skip to content

Effects of caffeine and carnitine in athletes

The effects of carnitine and caffeine supplementation on body fat percentage, oxidative stress, lipid profile, inflammatory and atherosclerotic factors in semi-professional athletes

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014100619411N1
Enrollment
30
Registered
2014-10-15
Start date
2014-10-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Athletes. Routine general health check-up of sports teams

Interventions

Intervention 1: Caffeine supplementation in gelatinized capsules, 6 mg/kg, 3 times per week, for 6 weeks. Intervention 2: Carnitine supplementation in gelatinized capsules, 2 g/kg, 3 times per week, f
Treatment - Drugs
Placebo
Caffeine supplementation in gelatinized capsules, 6 mg/kg, 3 times per week, for 6 weeks
Carnitine supplementation in gelatinized capsules, 2 g/kg, 3 times per week, for 6 weeks
Placebo (dextrose) in gelatinized capsules, 2 g/kg, 3 times per week, for 6 weeks

Sponsors

Ahvaz Jundishapur University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Male athletes aged 20 to 30 years old; playing soccer for approximately 2 years; body mass index in the normal range; without cardiovascular disease and muscular damage Exclusion criteria: weight loss diet over the past month, consumption of any sport supplements 8 weeks before the study, having acute and chronic illnesses, smoking

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Weigth changes. Timepoint: Before and after intervention. Method of measurement: Weight scale.;Body fat percentage. Timepoint: Before and after intervention. Method of measurement: Body fat Analyser.;Oxidative stress. Timepoint: Before and after intervention. Method of measurement: ELISA method.;Cardiovascular health: lipid factors(TG.TC,HDL,LDL),Fasting glucose, Free fatty acids, CRP. Timepoint: Before and after intervention. Method of measurement: ELISA and Spectrophotmetery methods.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Saeed Shirali

Ahvaz Jundishapur University of Medical Sciences

shirali-s@ajums.ac.ir+98 61 1373 8319

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026